Background
==========

The intestinal protozoan *Giardia duodenalis*is a common cause of waterborne outbreaks in western countries since the cysts are relatively resistant to water treatment, and in most developing countries the parasite is highly endemic \[[@B1],[@B2]\]. The clinical impact of *Giardia*infection ranges from mild self-limiting disease to life-threatening malnutrition \[[@B3]-[@B5]\].

Post-infectious complications have been described in children in developing countries, where giardiasis contributes to malnutrition and growth retardation with later risk for impaired cognitive function \[[@B6]\].

Also post-giardiasis complications in a western country have recently been described. We reported a high level of post-infectious fatigue (41%) and abdominal symptoms (38%) among 1017 cases two years after a waterborne outbreak in Bergen, Norway in 2004 \[[@B7],[@B8]\]. The aim of this study was to investigate risk factors associated with such manifestations.

Methods
=======

Study site and participants
---------------------------

Inclusion criteria was laboratory verified *Giardia*infection from the Bergen outbreak. All *Giardia*-positive cases diagnosed by stool microscopy (formalin-ether concentration) and/or antigen-test (ImmunoCard STAT! Cryptosporidium/*Giardia*rapid assay; Meridian Bioscience) at the local parasitology laboratory in Bergen were registered in the period from October 2004 to June 2005, and an additional 16 cases considered to be related to the outbreak were registered until December 2005. The majority of cases was registered in November 2004 (n = 863). A higher number than normal was registered also in 2005 (n = 172) after the water supply in December 2004 was considered free from *Giardia*cysts, probably due to protracted or secondary infections. A few cases known not to be infected in Bergen were excluded. According to this, a study population of 1262 cases, later referred to as \"all cases\", was defined.

The investigating laboratory is the only parasitology laboratory in the region, and prior to the outbreak about 50 cases a year were diagnosed, mainly infected abroad \[[@B9]\].

Questionnaire
-------------

In August 2006, two years after the peak of the outbreak, a questionnaire was mailed to all cases, followed by an additional letter to non-respondents one month later.

We asked about abdominal problems prior to giardiasis; among these if abdominal problems had ever led to any of the following: Hospitalisation, sick leave, use of medication, seeing a doctor or problems without seeking health care, or if they did not have abdominal problems prior to September 2004.

Cases were asked about the following symptoms during giardiasis: Diarrhoea, abdominal pain, weight loss, malaise, nausea, foul smell and bloating. They were also asked about sick leave (0, \<1, 1, 1-2 or \>2 weeks), delayed education (0, \<1, 1 or \> 1 semester), time before abdominal symptoms disappeared (\< 1, 1-3, 4-6 or 7-18 months) and number of treatment courses before abdominal symptoms ceased (0, 1, 2, \>2, or recovered during treatment but relapsed).

We also asked if they had present problems with abdominal symptoms and with fatigue. The results for these latter questions have been published previously \[[@B8]\]. Present symptoms including nausea, bloating, abdominal pain, diarrhoea, constipation and reduced appetite were recorded on a scale from 0 (no symptoms) to 10 (severe symptoms). These questions have previously been used in recording severity of symptoms in patients with irritable bowel syndrome (IBS) \[[@B10]\].

Number of cases working/studying was estimated as cases answering the questions concerning sick leave/delayed education, minus cases answering that they were not working/studying.

Abdominal symptoms were reported as \"no\", \"unsure\" or \"yes\" on the question \"Do you have abdominal symptoms now that you did not have prior to the *Giardia*infection?\" Fatigue was reported as \"less or same as usual\", \"more than usual\" or \"much more than usual\" on the question \"Do you have problems with fatigue?\" These were used as ordinal response variables in the statistical analyses.

Characteristics evaluated as possible risk factors
--------------------------------------------------

Whether protracted and severe *Giardia*infection could be associated with post-infectious fatigue or abdominal symptoms was studied, and number of treatment courses, delayed education and sick leave were all used as indices of protracted and severe infection in the statistical analyses. A sub-cohort of treatment resistant cases with mean symptom duration seven months, who had all been successfully treated in our out patient clinic, was also included in the statistical analyses. The characteristics and results from treatment of this cohort has been published previously \[[@B11]\]. Age, gender, previous abdominal problems and symptoms during infection were also evaluated as possible risk factors.

Statistical methods
-------------------

For each of the two ordinal response variables at two years follow-up, fatigue and abdominal symptoms, the possible risk factors were analysed as explanatory variables using ordinal logistic regression with the proportional odds model. In the proportional odds model the results are expressed as the ratio of the odds for a response above a certain level in the exposed to the odds for a response above this level in the unexposed. This odds ratio (OR) is modelled to be independent of the chosen level. First, for each of the response variables, simple ordinal logistic regression analysis was done for all risk factors. Then, all factors were included in a multiple ordinal logistic regression analysis (proportional odds model) \[[@B12]\]. From the analyses, unadjusted and adjusted odds ratios were estimated. To avoid loosing cases in the multiple regression analyses, missing values were included as valid categories in some variables as follows: \"Not recovered\" was included in the variable \"Treatment courses\", \"Not working\" in \"Sick leave\" and \"Not a student\" in \"Delayed education\". To evaluate the possible risk that these variables only reflect the response variables, the multiple regression analyses were performed with and without each of them. Age and gender were included into all models with no regards to significance. The final model included all variables with p \< 0.05 (likelihood ratio test). Statistical analyses were performed using SPSS 15.0 or STATA.

Ethics
------

Written informed consent was obtained. The regional ethics committee and the Privacy Ombudsman for Research approved the data collection and analyses of the study.

Results
=======

Patient characteristics
-----------------------

Patient characteristics are shown in Table [1](#T1){ref-type="table"}. The response rate was 81% (1017/1262), later referred to as \"respondents\". Median age among respondents was 31 years (range 3-93) and 64% were women, compared to 30 years (range 2-93) and 61% among all cases. Among the respondents, 722 (71%) were estimated to be working and 460 (45%) to be students. Prior to the *Giardia*outbreak, 12% of respondents (124/1017) had visited a doctor due to abdominal problems, 10% (98/1017) had had abdominal symptoms without seeking health care, 4% (42/1017) had used medication for such symptoms, 2% (19/1017) had been hospitalised and 2% (19/1017) had been on sick leave due to abdominal problems prior to the *Giardia*outbreak. A majority of 71% (718/1017) reported to have had no previous abdominal problems.

###### 

Age and gender of the respondents and non-respondents to a postal questionnaire compared to all *Giardia*-positive cases during an outbreak in Bergen, Norway in 2004.

  -----------------------------------------------------------------
  Characteristic     Respondents\   Non-respondents\   All cases\
                     N (%)          N (%)              N (%)
  ------------------ -------------- ------------------ ------------
  ***Total***        1017 (100)     245 (100)          1262 (100)

  ***Gender***                                         

   Female            647 (64)       117 (48)           764 (61)

   Male              370 (36)       128 (52)           498 (39)

  ***Age***(Years)                                     

   0-19^a^           62 (6)         25 (10)            87 (7)

   20-39             679 (67)       185 (76)           864 (68)

   40-59             211 (21)       32 (13)            243 (19)

   60-79             55 (5)         3 (1)              58 (5)

   80-100            10 (1)         0 (0)              10 (1)
  -----------------------------------------------------------------

^a^Among respondents, 13 cases (1%) were less than 5 years, 13 cases (1%) were 5-9 years, 12 (1%) cases were 10-14 years and 24 (2%) cases were 15-19 years old.

Abdominal symptoms and fatigue two years after infection was recorded from 38% (389/1017) and 41% (419/1017) respectively as previously reported \[[@B8]\] (Table [2](#T2){ref-type="table"}). Bloating was the symptom reported to be most severe (Table [2](#T2){ref-type="table"}).

###### 

Symptoms two years after *Giardia*infection in Bergen, Norway in 2004, among 1017 respondents to a questionnaire.

  Symptoms                   Cases^a^(%)   Symptom score^b^   
  -------------------------- ------------- ------------------ ------
  ***Fatigue***                                               
   Less or same as usual     511 (50)                         
   More than usual           306 (30)                         
   Much more than usual      113 (11)                         
  ***Abdominal symptoms***                                    
   No                        360 (35)                         
   Unsure                    228 (22)                         
   Yes                       389 (38)                         
  Bloating                   475 (47)      4.57 ± 0.13        5.00
  Diarrhoea                  467 (46)      3.80 ± 0.12        3.74
  Abdominal pain             442 (43)      3.64 ± 0.13        3.00
  Nausea                     416 (41)      2.23 ± 0.12        2.00
  Reduced appetite           398 (39)      1.60 ± 0.12        0.67
  Constipation               398 (39)      1.57 ± 0.12        0.66

^a^Number of persons reporting the symptoms. Percent of respondents (n = 1017).

^b^Symptoms scored from 0 (no symptoms) to 10 (severe symptoms).

^c^Standard error of the mean.

Giardia infection
-----------------

Symptoms during *Giardia*infection, as reported two years later are shown in Table [3](#T3){ref-type="table"}. Less than four weeks duration of symptoms, irrespective of treatment, was recorded in 18%. Only 1% became well without medication. Sick leave was reported by 46%, and almost half of these had been on sick leave for more than two weeks. Delayed education was reported in 33%, and 17% had one or more semester delay.

###### 

Distribution of factors during *Giardia*infection among 1017 cases in Bergen, Norway in 2004, reported two years later.

  Factors during *Giardia*infection          Cases (%)
  ------------------------------------------ -----------
  ***Symptoms***                             
   Diarrhoea                                 904 (89)
   Malaise                                   761 (75)
   Abdominal pain                            689 (68)
   Bloating                                  657 (65)
   Nausea                                    647 (64)
   Foul smell                                612 (60)
   Weight loss                               539 (53)
   None of these symptoms                    15 (2)
  ***Duration of abdominal symptoms***       
   \< 4 weeks                                185 (18)
   1-3 months                                193 (19)
   4-6 months                                88 (9)
   7-18 months                               62 (6)
  ***Number of treatment courses***          
   0                                         13 (1)
   1                                         348 (34)
   2 or more                                 153 (15)
   Recovered during treatment but relapsed   84 (8)
  ***Duration of sick leave*(n = 722)^a^**   
   No sick leave                             394 (54)
   \< 1 week                                 62 (9)
   1-2 weeks                                 110 (15)
   \> 2 weeks                                157 (22)
  ***Delayed education*(n = 460)^b^**        
   No delay                                  311 (68)
   \< 1 semester                             69 (15)
   1 semester                                44 (10)
   \> 1 semester                             36 (8)

^a^Percent of persons estimated to be working (n = 722).

^b^Percent of persons estimated to be students (n = 460).

Factors associated with fatigue and abdominal symptoms
------------------------------------------------------

The analyses of risk factors associated with abdominal symptoms and fatigue are presented in Table [4](#T4){ref-type="table"} and [5](#T5){ref-type="table"}, respectively.

###### 

Abdominal symptoms two years after *Giardia*infection reported in a cohort of 1017 cases, associated with patient characteristics and factors during giardiasis.

  Characteristics                                 N     Abdominal symptoms                                                             
  ----------------------------------------------- ----- -------------------- ---------- ---------- ------- --------- ------- --------- ----------------
  **Gender**                                                                                                                 0.029     
   Male                                           355   138 (39)             87 (25)    130 (37)   1.00              1.00              
   Female                                         622   222 (36)             141(23)    259 (42)   1.20    0.158     1.45              (1.04, 2.04)
                                                                                                                                       
  **Age^c^(years)**                               977                                              1.01    0.064     \-      Ns        \-
                                                                                                                                       
  **Abdominal problems before 2004 leading to**                                                                                        
   Visiting doctor                                119   35 (29)              39 (33)    45 (38)    1.13    0.516     \-      Ns        \-
   Hospitalisation                                17    4 (24)               8 (48)     5 (30)     1.04    0 925     \-      Ns        \-
   Sick leave                                     18    7 (39)               8 (44)     3 (17)     0.62    0.286     \-      Ns        \-
   Use of medication                              40    12 (30)              16 (40)    12 (30)    0.94    0.826             Ns        
   Problems without seeking health care           94    30 (32)              26 (28)    38 (40)    1.13    0.539     \-      Ns        \-
  **No abdominal problems before 2004**           883   330 (37)             202 (23)   351 (40)   1.18    0.220     \-      Ns        
                                                                                                                                       
  **Acute giardiasis**                                                                                                                 
   Diarrhoea                                      880   318 (36)             211 (24)   351 (40)   1.19    0.390     \-      Ns        \-
   Abdominal pain                                 674   212 (32)             160 (24)   302 (45)   2.05    \<0.001   \-      Ns        \-
   Weight loss                                    529   187 (35)             128 (24)   214 (41)   1.10    0.411     \-      Ns        \-
   Malaise                                        742   242 (33)             183 (25)   317 (43)   1.91    \<0.001   \-      Ns        \-
   Nausea                                         632   226 (36)             150 (24)   256 (41)   1.11    0.391     \-      Ns        \-
   Foul smell                                     595   178 (30)             146 (25)   271 (46)   2.00    \<0.001   \-      Ns        
   Bloating                                       645   176 (27)             158 (25)   311 (48)   3.20    \<0.001   1.51    0.023     (1.06, 2.16)
                                                                                                                                       
  **Treatment refractory infection^d^**           28    7 (25)               6 (21)     15 (54)    1.78    0.117     3.08    0.030     (1.11, 8.53)
                                                                                                                                       
  **Treatment courses^e^**                                                                                                   \<0.001   
   0 or 1                                         360   242 (67)             85 (24)    33 (9)     1.00              1.00              
   2 or more                                      237   99 (42)              69 (29)    69 (29)    3.23    \<0.001   3.39    \<0.001   (2.33, 4.94)
   Recovered during course but relapsed           3     1 (33)               1 (33)     1 (33)     4.38    0.166     5.05    Ns        (0.57, 45.11)
   Not recovered                                  374   16 (4)               73 (20)    285 (76)   30.54   \<0.001   32.81   \<0.001   (21.67, 49.65)
                                                                                                                                       
  **Sick leave^e^**                                                                                                          Ns        
   No sick leave                                  387   162 (42)             85 (22)    140 (36)   1.00              1.00              
   \< 1 week                                      61    20 (33)              19 (31)    22 (36)    1.21    0.460     \-      Ns        \-
   1-2 weeks                                      105   41 (39)              32 (31)    32 (31)    0.95    0.806     \-      Ns        \-
   \> 2 weeks                                     153   43 (28)              27 (18)    83 (54)    2.04    \<0.001   \-      Ns        \-
   Not working                                    241   85 (35)              60 (25)    96 (40)    1.26    0.150     \-      Ns        \-
                                                                                                                                       
  **Delayed education^e^**                                                                                                   0.020     
   No delay                                       306   140 (46)             65 (21)    101 (33)   1.00              1.00              
   \< 1 semester                                  67    25 (37)              15 (22)    27 (40)    1.40    0.175     1.06    Ns        (0.60, 1.89)
   1 semester                                     42    9 (21)               10 (24)    23 (55)    2.69    0.002     2.47    0.024     (1.13, 5.45)
   \> 1 semester                                  34    1 (3)                8 (24)     25 (74)    6.64    \<0.001   3.50    0.013     (1.30, 9.38)
   Not a student                                  379   141 (37)             91 (24)    147 (39)   1.36    0.031     3.14    Ns        (0.80, 1.63)

Abbreviations: OR, odds ratio; Ns, not significant; CI, confidence interval.

^a^Simple ordinal logistic regression analysis (proportional odds model).

^b^Ordinal logistic regression analysis. Multiple regression analysis included all variables in the table. Missing values; n = 205.

^c^Age as continuous variable in the statistical analysis.

^d^All cases successfully treated with albendazole + metronidazole, paromomycin or quinacrine + metronidazole after 30 (mean) weeks duration of infection \[[@B11]\].

^e^Categorical variable in the statistical analysis including the categories shown in the table. Likelihood-ratio test (STATA).

###### 

Fatigue two years after *Giardia*infection reported in a cohort of 1017 cases, associated with patient characteristics and factors during giardiasis.

  Characteristics                                 N     Fatigue                                                            
  ----------------------------------------------- ----- ---------- ---------- ---------- ------ --------- ------ --------- ---------------
  **Gender**                                                                                                     Ns        
   Male                                           338   199 (59)   107 (32)   32 (10)    1.00             1.00             
   Female                                         592   312 (53)   199 (34)   81 (14)    1.32   0.038     \-               
                                                                                                                           
  **Age^c^(years)**                               930                                    1.02   \<0.001   1.02   0.007     (1.01, 1.03)
                                                                                                                           
  **Abdominal problems before 2004 leading to**                                                                            
   Visiting doctor                                114   49 (43)    50 (44)    15 (13)    1.56   0.020     \-     Ns        
   Hospitalisation                                14    4 (29)     8 (57)     2 (14)     2.21   0.113     \-     Ns        
   Sick leave                                     17    6 (35)     10 (59)    1 (6)      1.60   0.309     \-     Ns        
   Use of medication                              35    15 (43)    18 (51)    2 (6)      1.31   0.414     \-     Ns        
   Problems without seeking health care           95    45 (47)    40 (42)    10 (11)    1.26   0.256     2.13   0.025     (1.10, 4.15)
  **No abdominal Problems before 2004**           662   380 (57)   198 (30)   84 (13)    0.78   0.081     \-     Ns        
                                                                                                                           
  **Acute giardiasis**                                                                                                     
   Diarrhoea                                      839   456 (54)   279 (33)   104 (12)   1.28   0.255     \-     Ns        
   Abdominal pain                                 646   322 (50)   236 (37)   88 (14)    1.95   \<0.001   \-     Ns        
   Weight loss                                    506   255 (50)   180 (36)   71 (14)    1.50   0.002     \-     Ns        
   Malaise                                        714   334 (47)   277 (39)   103 (14)   5.03   \<0.001   3.68   \<0.001   (2.25, 6.01)
   Nausea                                         604   302 (50)   215 (36)   87 (14)    1.81   \<0.001   \-     Ns        
   Foul smell                                     580   290 (50)   201 (35)   89 (15)    1.80   \<0.001   \-     Ns        
   Bloating                                       622   311 (50)   224 (36)   87 (14)    1.84   \<0.001   \-     Ns        
                                                                                                                           
  **Treatment refractory infection^d^**           29    13 (45)    11 (38)    5 (17)     1.52   0.236     \-     Ns        
                                                                                                                           
  **Treatment courses^e^**                                                                                       \<0.001   
   0 or 1                                         326   249 (76)   68 (21)    9 (3)      1.00             1.00             
   2 or more                                      227   128 (56)   77 (34)    22 (10)    2.55   \<0.001   1.98   0.002     (1.28, 3.07)
   Recovered during course but relapsed           3     2 (67)     1 (33)     0 (0)      1.50   0.742     2.37   Ns        (0.19, 29.08)
   Not recovered                                  371   129 (35)   160 (43)   82 (22)    6.39   \<0.001   6.20   \<0.001   (4.16, 9.24)
                                                                                                                           
  **Sick leave^e^**                                                                                              0.001     
   No sick leave                                  368   232 (63)   106 (29)   30 (8)     1.00             1.00             
   \< 1 week                                      58    30 (52)    24 (41)    4 (7)      1.45   0.180     0.93   Ns        (0.49, 1.77)
   1-2 weeks                                      98    63 (64)    29 (30)    6 (6)      0.93   0.740     0.72   Ns        (0.42, 1.23)
   \> 2 weeks                                     150   55 (37)    50 (33)    45 (30)    3.63   \<0.001   2.26   \<0.001   (1.45, 3.53)
   Not working                                    232   125 (54)   84 (36)    23 (10)    1.42   0.035     1.08   Ns        (0.71, 1.63)
                                                                                                                           
  **Delayed education^e^**                                                                                       0.001     
   No delay                                       291   205 (70)   67 (23)    19 (7)     1.00             1.00             
   \< 1 semester                                  66    31 (47)    30 (46)    5 (8)      2.34   0.002     1.79   0.049     (1.00, 3.19)
   1 semester                                     39    13 (33)    17 (44)    9 (23)     4.64   \<0.001   2.80   0.004     (1.39, 5.66)
   \> 1 semester                                  35    8 (23)     13 (37)    14 (40)    9.21   \<0.001   3.88   \<0.001   (1.82, 8.30)
   Not a student                                  357   188 (53)   121 (34)   48 (13)    2.17   \<0.001   1.51   0.033     (1.03, 2.21)

Abbreviations: OR, odds ratio; Ns, not significant.

^a^Simple ordinal logistic regression analysis (proportional odds model).

^b^Ordinal logistic regression analysis (proportional odds model). Multiple regression analysis included all variables in the table. Missing values; n = 241

^c^Age as continuous variable in the statistical analysis.

^d^All cases successfully treated with albendazole + metronidazole, paromomycin or quinacrine + metronidazole after 30 (mean) weeks duration of infection \[[@B11]\].

^e^Categorical variable in the statistical analysis including the categories shown in the table. Likelihood-ratio test (STATA)

More than one course of treatment for giardiasis, as well as delayed education, was significantly associated with both fatigue and abdominal symptoms in all analyses. Previous abdominal problems were not significantly associated with post-infectious abdominal symptoms in any analyses.

Female gender turned out not to be significantly associated with abdominal symptoms when the variable \"treatment courses\" was left out from the multiple regression analysis (data not shown).

Discussion
==========

We have previously reported a high prevalence of fatigue (41%, 419/1017) and abdominal symptoms (38%, 389/1017), and a highly significant association between these symptoms, two years after the Bergen outbreak \[[@B8]\]. In this study we report an association between protracted and severe *Giardia*infection and such symptoms.

Fatigue has been described following Q-fever, *Epstein Barr*virus infection, *Ross River*virus infection, brucellosis, Lyme disease, viral meningitis and Dengue fever, and in the first three of these, severe infection was a risk factor \[[@B13]-[@B16]\].

In a sub-cohort of referred cases after the Bergen outbreak, 81% (66/82) fulfilled the Rome II criteria for IBS \[[@B17]\]. Post-infectious (PI)-IBS has been reported with a median prevalence of around 10% following gastroenteritis of various aetiology; *Campylobacter*\[[@B18]-[@B20]\], *Salmonella*\[[@B21]-[@B23]\], *Shigella*\[[@B24]-[@B26]\], *Escherichia coli*\[[@B20]\] and *Trichinella spiralis*\[[@B27]\], and severe infection was the most important risk factor in these reports \[[@B24],[@B28]-[@B30]\].

A possible weakness in our definition of indices of protracted and severe *Giardia*infection is that sick leave or delayed education may be signs of PI-IBS or fatigue rather than protracted infection or inflammation. Particularly those reporting \"\>1 semester delayed education\", but also \"sick leave \> 2 weeks\", could potentially be cases actually reporting persistent symptoms, but excluding them from the statistical analyses would have created a selection bias. More than one treatment course is a reliable index of persistent infection and the finding of this as a highly significant risk factor in all analyses supports the hypothesis that protracted and severe infection may cause post-infectious complications. However, some patients may not have had stool samples tested between the courses, and may therefore have experienced post-infectious complaints rather than protracted infection. Results regarding the sub-cohort of referred treatment refractory cases must be interpreted with caution due to the very low sample size (n = 29) \[[@B11]\].

If our findings are causal, then the surprisingly high level of fatigue and abdominal symptoms reported, may have two possible explanations: A substantial number of cases had protracted infection due to delayed treatment explained by late detection of the outbreak \[[@B7]\], and/or the infection caused inflammation in a high number of cases, also after clearing the parasites \[[@B31]\]. Giardiasis may cause damage to the intestinal epithelial brush border, villous atrophy and inflammation \[[@B32]\]. In duodenal biopsies from a sub-cohort of 124 cases with symptoms for 8 months (mean) from the Bergen outbreak, inflammation was found in 47% \[[@B31]\], which is surprisingly high compared to a previous report of duodenal inflammation in 4% of 462 *Giardia*cases from Germany \[[@B33]\]. This supports that protracted *Giardia*infection, and possibly protracted intestinal inflammation, may have induced PI-IBS and fatigue in this cohort. Low-grade inflammation in gut-mucosa has been described as a possible mechanism for IBS also following other infections \[[@B34]\].

The high prevalence of inflammation in this outbreak may be explained by immunological host factors, but probably also by parasite virulence factors. Studies addressing the possible association between *Giardia*genotypes and clinical manifestations have shown different results: Both genotype A and B have been responsible for severe symptoms, with the genotype less prevalent in the community responsible for more severe clinical manifestation \[[@B35]-[@B38]\]. In Norway 11% of raw water samples contains *Giardia*parasites in low concentrations, most commonly genotype A, while the outbreak strain in Bergen was assemblage B \[[@B39],[@B40]\]. Previous studies from the outbreak suggest that some sub-genotypes induced a more severe infection \[[@B11],[@B41]\], and one may speculate if particular sub-genotypes lead to an immune reaction responsible for protracted low-grade inflammation. Also in IBS following infections other than giardiasis, toxicity within species has been reported as a risk factor, as in *Campylobacter*infection \[[@B18]\].

Age was significantly associated with fatigue as previously reported from this cohort \[[@B8]\], which is in line with findings in a Norwegian population study \[[@B42]\]. We did not find any significant association between age and abdominal symptoms. Age \>60 years was protective against PI-IBS in one study \[[@B29]\], and one mechanism was suggested to be that the gut in older subjects might be less reactive to infection \[[@B43]\].

Female gender seemed to be a risk factor for both fatigue and abdominal symptoms in some but not all analyses, and this finding must therefore be interpreted with caution. An association between chronic fatigue and female gender has been reported in other studies \[[@B13],[@B42],[@B44]-[@B46]\]. Female gender has also been associated with PI-IBS in some reports; however, this association was no longer significant when analyses were adjusted for psychological disturbances \[[@B19],[@B28],[@B29],[@B47]\].

Malaise during infection was associated with fatigue, and bloating with abdominal symptoms. This may either indicate recall bias influenced by symptoms present at the time of reporting, or a real risk of complications if these symptoms are prominent.

There was no association between previous abdominal problems and post-infectious abdominal symptoms. The finding that \"previous abdominal problems without seeking health care\" was associated with fatigue should be interpreted with caution since other factors measuring previous abdominal problems were not associated. The possible impact of recall bias on the outcome regarding previous abdominal problems in this study may be less since the questions were phrased as facts (\"hospitalised\" etc) rather than symptoms.

Chronic *Giardia*infection may develop in 15% of patients if not treated \[[@B4]\], and may be misdiagnosed as IBS due to similar symptoms \[[@B48]\]. *Giardia*was found in 6.5% of IBS cases in one study from Italy \[[@B49]\], and in a meta-analysis from the Nordic countries, giardiasis was found in 3.0% of the asymptomatic, and in 5.8% of the symptomatic, population \[[@B50]\].

We have previously shown that all referred treatment refractory cases after the Bergen outbreak eradicated the parasite, evaluated by seven negative stool samples up to four weeks after treatment \[[@B11]\]. In 25 *Giardia*negative patients from this outbreak, treatment with metronidazole/albendazole or tetracycline/folic acid was not effective, and cryptic giardiasis was therefore excluded \[[@B51]\]. We have also described that IBS persisted in patients after normalisation of duodenal biopsies \[[@B17]\]. These reports support that chronic infection is not the cause of fatigue and abdominal symptoms in this cohort.

A major strength of the study is the large number of cases, and the high response rate. A limitation may be the risk of over-reporting of symptoms since local authorities have accepted to compensate any economical loss due to the infection. Possible reporting bias due to limitations in the questionnaire could have been reduced if validated measures of chronic fatigue and IBS had been used in a controlled study. Also, the study lacks information on co-morbidity and professional background. It is unclear whether these limitations have influenced the outcome of the study. On the other hand, the study was initiated by clinicians after observing a substantial number of patients with severe chronic fatigue and/or abdominal symptoms after giardiasis, supporting that self reporting of symptoms associated with giardiasis in this cohort is consistent with clinical observations.

Conclusions
===========

Protracted and severe *Giardia*infection, or possibly inflammation, seems to be a risk factor for post-infectious fatigue and abdominal symptoms two years after clearing the parasites. These symptoms are often pronounced, reduce quality of life and have economical implications in the society. If the observed association is causal, shortening the duration of *Giardia*infection by early diagnosis and treatment may be important also in order to reduce the risk for such complications.

Competing interests
===================

The authors declare that they have no competing interests.

Authors\' contributions
=======================

KM, KH, GR, KAW, TH and NL participated in the design of the study. KM collected data and drafted the manuscript. GEE and KM performed the statistical analyses. All authors contributed to interpretation of data, revision of the manuscript, and approved the final manuscript.

Pre-publication history
=======================

The pre-publication history for this paper can be accessed here:

<http://www.biomedcentral.com/1471-2334/9/206/prepub>

Acknowledgements
================

We thank Grete Thormodsæter (Department of Medicine, Haukeland University Hospital) for technical help in collecting data, and Bjørn Blomberg (Department of Medicine, Haukeland University Hospital) for technical assistance in creating the databases.

No external funding was received to conduct this study.
